Oral progestagens before menopause and breast cancer risk

We examined the relationship between use of progestagen-only before menopause (except for mini-pills) after the age of 40 and invasive breast cancer risk in 73 664 women from the French E3N cohort study (mean age at start of follow-up, 51.8 years; mean duration of follow-up, 9.1 years). A total of 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabre, A, Fournier, A, Mesrine, S, Desreux, J, Gompel, A, Boutron-Ruault, M-C, Clavel-Chapelon, F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062495/
https://www.ncbi.nlm.nih.gov/pubmed/17299388
http://dx.doi.org/10.1038/sj.bjc.6603618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062495/
https://www.ncbi.nlm.nih.gov/pubmed/17299388
http://dx.doi.org/10.1038/sj.bjc.6603618

Ejemplares similares